 |
 |
| Teikoku Seiyaku’s medicated patches and plasters are currently sold in more than 40 countries worldwide. One of the Flector Products, anti-inflammatory and analgesic plasters, is marketed in Europe and other countries by IBSA Institut Biochimique SA and IBSA International SA in Switzerland. Lidoderm, an analgesic plaster for the treatment of post-herpetic neuralgia, is the first prescription plaster approved in the United States and has been marketed by Endo Pharmaceuticals. |
|
|
 |
|
| Our subsidiaries in the United States and in the United Kingdom conduct post-marketing surveillance and disseminate information about Teikoku Seiyaku. The U.S. subsidiary takes full advantage of its location in Silicon Valley, home to scientists and professionals from all over the world, to conduct dynamic research programs. In addition, we have obtained approval in Japan for Dovonex, an ointment for treating psoriasis vulgaris produced by LEO Pharmaceutical Products in Denmark, and now imported for domestic sale. It is marketed by our sales partner to healthcare organizations throughout Japan. |
|
